Performance of chromogenic in situ hybridization on testing HER2 status in breast carcinoma

被引：0
|
作者：
Bchir, A. [1 ]
Abdessayed, N. [1 ]
Ben Abdelkhader, A. [1 ]
Mokni, M. [1 ]
机构：
[1] Farhat Hached Univ Hosp, Sousse, Tunisia
来源：
HISTOPATHOLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
297
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [31] Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization
    Xiu Nie
    Jun He
    Yan Li
    Dan-zhen Pan
    Hua-xiong Pan
    Mi-xia Weng
    Xiu-ping Yang
    Chun-ping Liu
    Tao Huang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 379 - 384
  • [32] Comparison of fluorescence in situ hybridization and dual color chromogenic in situ hybridization for the assessment of HER2 status on core-needle breast cancer biopsies
    Suarez-Gauthier, A.
    Garcia-Garcia, E.
    Conde, E.
    Munoz, A.
    Torres, M.
    Miro, C.
    Garcia-Estevez, L.
    Lopez-Rios, F.
    CANCER RESEARCH, 2009, 69 (02) : 209S - 209S
  • [33] Accurate Assessment of HER2 Gene Status for Invasive Component of Breast Cancer by Combination of Immunohistochemistry and Chromogenic In Situ Hybridization
    聂秀
    贺骏
    李燕
    潘丹珍
    潘华雄
    翁密霞
    杨秀萍
    刘春萍
    黄韬
    Current Medical Science, 2013, (03) : 379 - 384
  • [34] Accurate Assessment of HER2 Gene Status for Invasive Component of Breast Cancer by Combination of Immunohistochemistry and Chromogenic In Situ Hybridization
    聂秀
    贺骏
    李燕
    潘丹珍
    潘华雄
    翁密霞
    杨秀萍
    刘春萍
    黄韬
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2013, 33 (03) : 379 - 384
  • [35] Comparison of dual-colour chromogenic in-situ hybridization and fluorescence in-situ hybridization in the assessment of HER2 gene amplification in breast carcinoma
    Conlon, Susan
    Colgan, Aoife
    Allen, David
    O'Grady, Anthony
    Kay, Elaine W.
    HISTOPATHOLOGY, 2011, 58 (02) : 320 - 321
  • [36] Prospective Testing for Her2 Using Simultaneous Immunohistochemistry (IHC) and Chromogenic In Situ Hybridization (CISH)
    De Luca-Johnson, Javier
    Bryant, Britni R. E.
    Mitchell, Jeannette
    Cortright, Valerie
    Weaver, Donald L.
    Goodwin, Andrew
    Harmon, Maureen
    Ambaye, Abiy
    LABORATORY INVESTIGATION, 2017, 97 : 505A - 505A
  • [37] Prospective Testing for Her2 Using Simultaneous Immunohistochemistry (IHC) and Chromogenic In Situ Hybridization (CISH)
    De Luca-Johnson, Javier
    Bryant, Britni R. E.
    Mitchell, Jeannette
    Cortright, Valerie
    Weaver, Donald L.
    Goodwin, Andrew
    Harmon, Maureen
    Ambaye, Abiy
    MODERN PATHOLOGY, 2017, 30 : 505A - 505A
  • [38] Analysis of HER2 by chromogenic in situ hybridization and immunohistochemistry in lymph node-negative breast carcinoma:: prognostic relevance
    Peiro, Gloria
    Aranda, Francisco I.
    Adrover, Encarnal
    Niveiro, Maria
    Alenda, Cristina
    Paya, Artemio
    Segui, Javier
    HUMAN PATHOLOGY, 2007, 38 (01) : 26 - 34
  • [39] Dual-colour chromogenic in-situ hybridization is a potential alternative to fluorescence in-situ hybridization in HER2 testing
    Hwang, Cheng-Cheng
    Pintye, Mariann
    Chang, Liang-Che
    Chen, Huang-Yang
    Yeh, Kun-Yan
    Chein, Hui-Ping
    Lee, Nin
    Chen, Jim-Ray
    HISTOPATHOLOGY, 2011, 59 (05) : 984 - 992
  • [40] Comparison of fluorescence in situ hybridization and dual colour chromogenic in situ hybridization for the assessment of HER2 status on gastric cancer biopsies
    Gomez-Martin, C.
    Garcia-Garcia, E.
    Suarez-Gauthier, A.
    Conde, E.
    Lopez-Rios, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 404 - 404
12345